Patients' concerns about and problems experienced with discontinuation of antidepressants

International Journal of Pharmacy Practice

Volumn 15, Issue 4, 2007, Pages 291-293

  Van Geffen, E C G ^a,b   Brugman, M ^a,b   Van Hulten, R ^a   Bouvy, M L ^a,c   Egberts, A C G ^a   Heerdink, E R ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c SIR Institute for Pharmacy Practice and Policy   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL PRACTICE; DRUG MONITORING; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; PATIENT ATTITUDE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT PLANNING;

EID: 37049015082     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/ijpp.15.4.0006     Document Type: Article

References (13)

1. National Institute for Clinical Excellence. Quick reference guide: depression; the management of depression in primary and secondary care (Clinical Guideline 23). London: National Institute for Clinical Excellence; 2004. www.nice.org.uk/pdf/CG023quickrefguide.pdf (accessed 21 July 2007).
2. Lin EHB, Von Korff M, Katon W et al. The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care 1995;33:67-74.
3. Meijer WEE, Heerdink ER, Leufkens HMG et al. Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol 2004;60:57-61.
4. Meijer WEE, Bouvy ML, Heerdink ER, Urquhart J, Leufkens HMG. Spontaneous lapses in dosing during chronic treatment with selective serotonin reuptake inhibitors. Br J Psychiatry 2001;179:519-22.
5. Bambauer KZ, Adams AS, Zhang F et al. Physicians alerts to increase antidepressant adherence. Arch Intern Med 2006;166: 498-504.
6. van Geffen ECG, Hugtenburg JG, Heerdink ER, van Hulten RP, Egberts ACG. Discontinuation symptoms in users of selective serotonin reuptake inhibitors in clinical practice: tapering versus abrupt discontinuation. Eur J Clin Pharmacol 2005;61:303-7.
7. Taylor D, Stewart S, Connoly A. Antidepressant withdrawal symptoms telephone calls to a national medication helpline. J Affect Disord 2006;95:129-33.
8. Egberts ACG, Smulders M, De Koning FHP, Meyboom RHB, Leufkens HMG. Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals. BMJ 1996;313:530-1.
9. Croghan TW, Tomlin ME, Pescosolido BA et al. American attitudes toward and willingness to use psychiatric medications. J Nerv Ment Disord 2003;191:166-74.
10. Pound P, Britten N, Morgan M et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med 2005;61:133-55.
11. Demyttenaere K, Enzlin P, Dewé W et al. Compliance with antidepressants in a primary care setting, 1: beyond lack of efficacy and adverse events. J Clin Psychiatry 2001;62(suppl. 22):30-3.
12. Maddox J, Levi M, Thompson C. The compliance with antidepressants in general practice. J Psychopharmacol 1994;8:48-53.
13. Young HN, Bell RA, Epstein RM, Feldman MD, Kravitz RL. Types of information physicians provide when prescribing antidepressants. J Gen Intern Med 2006;21:1172-7.